FDA ap­pears un­con­vinced by Pfiz­er's case for Covid-19 boost­er in lead up to ad­comm

At around 9 a.m. on Wednes­day morn­ing, the FDA re­leased Pfiz­er’s de­tailed case to the agency and its out­side ad­vi­sors for au­tho­riz­ing Covid-19 boost­er dos­es …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER